Cat.#: ACPP-1301
| Despition | SHISA9 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1833 | Human CRMP1 Protein (AC1833) | 5 µg | inquiry |
| ACPP-1070 | Human Neuron Specific Enolase (Active) (AC1070) | 100 µg | inquiry |
| ACPP-1547 | Human CA14 Protein (AC1547) | 5 µg | inquiry |
| ACPP-1575 | Human HMOX1 Protein (AC1575) | 10 µg | inquiry |
| ACPP-1346 | GFAP Blocking Peptide (AC1346) | 250 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
| ACPP-1458 | Mouse LGALS3 Protein (AC1458) | 2 µg | inquiry |
| ACPP-1182 | Recombinant Cynomolgus macaque Midkine Protein (Fc Tag) (AC1182) | 10 µg | inquiry |
| ACPP-1482 | Human FGFR1 Protein (AC1482) | 2 µg | inquiry |
| ACPP-1460 | Mouse GMFB Protein (AC1460) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.